Ken Walsh – Director at Navigant Life Sciences

  • Over 15 years of extensive pricing strategic management and regulatory consulting experience with top global pharmaceutical firms in the UK, USA and across Asia

    Comprehensive knowledge of integrated issues regarding the evolving global healthcare environment, U.S., European and emerging markets market access pricing and reimbursement, public policy and product commercialization.

    Specialties: Qualitative and Quantitative pharmaceutical global pricing and market access strategy development


Leave a Reply


Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.